AI Deals Drive Strong Revenue Growth
Mphasis's financial results for the fourth quarter of FY26 showed significant revenue and profit increases, driven by a strong pipeline of AI-focused deals. The company announced revenue of ₹4,242.67 crore, up 14.4% year-over-year, and a net profit of ₹509.64 crore, a 14.1% increase. AI-related deals were a major factor, representing about 69% of its growing pipeline and 60% of its FY26 Total Contract Value (TCV) wins, which totaled $2.1 billion. This performance significantly outpaced its five-year average sales growth. Direct revenue grew 9.2% year-over-year in constant currency. The EBIT margin improved to 15.4% from 15.2% sequentially, reflecting improved operations as revenue grew. The board recommended a final dividend of ₹62 per share for FY26.
Premium Valuation Amidst Competition
However, Mphasis's stock trades at a higher valuation than many of its major Indian IT competitors. Its trailing twelve-month (TTM) Price-to-Earnings (P/E) ratio is approximately 23-24x. In comparison, Tata Consultancy Services (TCS) trades around 17.0x, Infosys at 16.0x, and Wipro near 14.43x. This premium valuation appears high given that Mphasis's historical growth rates have trailed industry averages over the last five years.
The Threat of "AI Deflation"
A major challenge for the entire IT sector is 'AI deflation,' which could hurt future profit margins. This happens when AI's efficiency gains are used to offer lower prices on existing IT services to clients. Experts predict this could cause 2-3% annual revenue reduction in this segment for the next few years. While AI opens new business and deal opportunities, reduced pricing on older services may cancel out these gains, especially for companies with many existing contracts. This trend makes it uncertain if current profit margins can be maintained as AI use grows.
Structural Risks and Analyst Views
Risks go beyond just AI deflation. Analysts point out that large projects focused on cost-cutting and AI adoption can be difficult to execute and may face lower margins due to fierce price competition. Mphasis's market share has shrunk over time, even with its strong recent quarterly performance. While many analysts recommend 'Buy' or 'Outperform' ratings from firms such as Motilal Oswal, Choice Institutional Equities, and Nuvama, their price targets vary widely. Some analyses suggest a general leaning towards 'Hold' ratings, signaling caution. Nomura's 'Neutral' rating also reflects differing views among investors.
Future Outlook and Management Continuity
Looking ahead, Mphasis is expected to see revenue and profit growth in the low double-digits annually from FY26 to FY29. The company's focus on AI and its NeoIP platform are considered key strengths. However, these efforts will face challenges from global economic uncertainty and the ongoing risk of AI deflation. The stock price, currently trading around ₹2,276.70 (below its 200-day moving average as of April 30, 2026), suggests some investor caution about short-term performance. The reappointment of CEO Nitin Rakesh for another five years provides management continuity.
